Novartis to consolidate holding in Indian subsidiary
This article was originally published in Scrip
Executive Summary
Novartis is launching a a tender offer to acquire an additional 39% stake in its majority-owned Indian subsidiary, Novartis India, from public shareholders at Rs351 per share.